Infliximab in treatment of refractory multisystem inflammatory syndrome in children with severe cardiac dysfunction

Infliximab in treatment of refractory multisystem inflammatory syndrome in children with severe cardiac dysfunction

Multisystem inflammatory syndrome in children (MIS-C) has emerged as one of the several challenges thrown by the ongoing severe acute respiratory syndrome-coronavirus 2 pandemic. Although diagnostic criteria of MIS-C have now been established to raise the clinical suspicion for the condition, the Ka...

Full description

Saved in:
Bibliographic Details
Main Authors: Guruprasad Hassan Shankar, Jitendra S Oswal, Bhakti U Sarangi, Ajay Walimbe, Prithvichandra Markal, Karthik V Badarayan
Format: Article
Language:English
Published: SAGE Publishing 2022-01-01
Series:Indian Journal of Rheumatology
Subjects:
intravenous immunoglobulin
kawasaki disease
methylprednisolone
severe acute respiratory syndrome-coronavirus 2
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2022;volume=17;issue=2;spage=166;epage=169;aulast=
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2022;volume=17;issue=2;spage=166;epage=169;aulast=

Similar Items